2nd EUROPEAN CONFERENCE ON GENE THERAPY OF CANCER
King's College London, 7 and 8 September 1995
REGISTRATION
Contact the Conference Secretariat, European Conference on Gene
Therapy of Cancer, Department of Molecular Medicine, King's College
School of Medicine and Dentistry, Rayne Institute, 123 Coldharbour
Lane, London SE5 9NU, UK.
Tel: 0171 346 3126 Fax: 0171 733 3877.
E-mail: mkuiper at hgmp.mrc.ac.uk (please include full postal address).
DEADLINE FOR ABSTRACTS
31 July 199
SCIENTIFIC ADVISORY COMMITTEE
Peter Beverley, London Nick Lemoine, London
Claudio Bordignon, Milan David Linch, Londo
Odile Cohen-Haguenauer, Paris Roland Mertelsmann, Freiburg
Mary Collins, London Ghulam Mufti, London
Gus Dagleish, London Karol Sikora, London
Mike Dexter, Manchester Robert Sobol, San Diego
Farzin Farzaneh, London Joyce Taylor-Papadimitriou, London
Gordon Freeman, Boston Dinko Valerio, Rijswijk
Scott Freeman, New Orleans Robin Weiss, London
PROGRAMME
7 S E P T E M B E R 1 9 9 5
SESSION 1 - STRATEGIES AND DELIVERY SYSTEMS
09.00 Introduction and Welcome
09.15 Chair: Robin Weiss
09.30 Francois-Loic Cosset - Retroviral vectors for receptor specific
ligand mediated targeting
10.00 Walter Gunzburg - Breast specific promoters
10.30 K K Wong - Adeno-associated virus gene delivery to
haematopoietic stem cells
11.00 Coffee Break
11.30 Yoshikazu Sugimoto - MDR1 and IRES vectors as a drug-selectable
gene delivery system
12.00 Natasha Caplen - Liposome mediated gene transfer
12.30 Lunch Break
SESSION 2 - TUMOUR IMMUNOLOGY
13.30 Chair: Peter Beverley
13:45 Vincent Brichard - Antigens recognised by anti-tumour CTL:
tumour specificity and perspectives for immunotherapy of cancer
14:15 Hans Stauss - T cell immunity to oncogenic proteins
14:45 Dorothy Crawford - EBV antigens
15:15 Tea break
15:45 Per Peterson - In vitro activation of tumour-specific cytotoxic
T-lymphocytes
16:15 Ronald Schwartz - The molecular basis of costimulation and
anergy in murine T cell clones
16.45 Short presentation selected from submitted abstracts
17.00 Poster Viewing/Trade Exhibition/Cocktail Reception
-19.30
8 S E P T E M B E R 1 9 9 5
SESSION 3 - IMMUNE GENE THERAPY
09.00 Chair: Joyce Taylor-Papadimitriou
09:15 Laurence Zitvogel - Cancer vaccines engineered with IL-4/
IL-12+B7-1: towards the adaptive immunotherapy using
genetically modified dendritic cells
09:45 Mary Collins - Designing melanoma vaccines
10:15 James Zwiebel - IL2 modified endothelial cells for tumour
targeting
10:45 Coffee break
11:15 Antonio Lanzavecchia - Alloantigen stimulation of tumour
rejection
11:45 Freda Stevenson - Idiotypic vaccination against B-cell lymphoma
12:15 Short presentation: Farzin Farzaneh - B7.1/IL2 autologous
vaccination
12:30 Lunch
SESSION 4 - NON-IMMUNE GENE THERAPY
13.30 Chair: Claudio Bordignon
13.45 Mike Dexter - gene delivery to haematological stem cells
14.15 Nick Lemoine - Genetically directed enzyme prodrug therapy
using tumour- and tissue-selective promoters
14.45 Giovanni Martinelli - Therapeutic role of antisense
oligonucleotides in haematological malignancies
15.15 Tea break
15.45 Scott Freeman - The mechanism of tumour killing using suicide
gene therapy
16.15 Short presentation
16.30 Robert Sobol - Summary of Gene Therapy of Cancer
17.00 Close
